Insider Trading & Ownership - COLUMN GROUP III GP LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for COLUMN GROUP III GP LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-04
Purchase(A)
2024-04-17
4:14 pm
Surrozen Inc.SRZNCOLUMN GROUP III GP LP
COLUMN GROUP III-A LP
COLUMN GROUP III LP
10% Owner
193,548$15.5$2,999,994326,992
(Indirect)
View
2024-04-04
Purchase
2024-04-08
4:23 pm
Surrozen Inc.SRZNCOLUMN GROUP III GP LP
COLUMN GROUP III-A LP
COLUMN GROUP III LP
10% Owner
193,548$15.5$2,999,9942,236,955
(Indirect)
View
2024-02-12
Purchase
2024-02-14
4:15 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
2,222,222$4.5$9,999,99922,999,565
(Indirect)
View
2023-03-10
Purchase
2023-03-14
4:12 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
6,779$2.5956$17,59620,777,343
(Indirect)
View
2023-02-08
Purchase
2023-02-10
4:32 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
1,500,000$2.6$3,900,00020,770,564
(Indirect)
View
2023-01-19
Purchase
2023-01-23
4:25 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
69,739$2.4979$174,20119,270,564
(Indirect)
View
2023-01-17
Purchase
2023-01-19
4:18 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
185,151$2.5105$464,82719,200,825
(Indirect)
View
2022-11-21
Purchase
2022-11-23
4:12 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
9,615,384$2.6$24,999,99819,015,674
(Indirect)
View
2021-02-17
Sale
2021-02-19
5:31 pm
CONSTELLATION PHARMACEUTICALS INCCNSTCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
COLUMN GROUP GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Kutzkey Tim
10% Owner
10,000$36.95$369,5036,230,638
(Indirect
Direct)
View
2020-11-16
Sale
2020-11-18
7:06 pm
Revolution Medicines Inc.RVMDCOLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
PONOI CAPITAL LP
Ponoi Capital II LP
Ponoi Management LLC
Ponoi II Management LLC
Kutzkey Tim
GOEDDEL DAVID V
10% Owner
2,027,156$36.4$73,788,4785,950,228
(Indirect
Direct)
View
2020-09-01
Purchase
2020-09-03
5:32 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Svennilson Peter
GOEDDEL DAVID V
Director
10% Owner
64,089$17.65$1,131,35818,242,932
(Indirect
Direct)
View
2020-08-27
Purchase
2020-08-31
5:02 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
GOEDDEL DAVID V
Svennilson Peter
Director
10% Owner
62,494$17.83$1,114,38218,178,843
(Indirect
Direct)
View
2020-08-21
Purchase
2020-08-25
6:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
GOEDDEL DAVID V
Svennilson Peter
Director
10% Owner
18,445$17.96$331,34918,116,349
(Indirect
Direct)
View
2020-08-13
Purchase
2020-08-17
7:12 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
GOEDDEL DAVID V
Svennilson Peter
Director
10% Owner
64,313$17.65$1,135,36218,097,904
(Indirect
Direct)
View
2020-07-30
Purchase
2020-08-03
5:57 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
GOEDDEL DAVID V
Svennilson Peter
Director
10% Owner
732$17.99$13,16918,033,591
(Indirect
Direct)
View
2020-07-28
Purchase
2020-07-30
8:08 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
GOEDDEL DAVID V
Svennilson Peter
Director
10% Owner
4,105$17.99$73,84918,032,859
(Indirect
Direct)
View
2020-07-24
Purchase
2020-07-28
5:40 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
GOEDDEL DAVID V
Svennilson Peter
Director
10% Owner
72,583$17.93$1,301,64318,028,754
(Indirect
Direct)
View
2020-07-22
Purchase
2020-07-23
5:39 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP II LP
COLUMN GROUP GP LP
Column Group II GP LP
Column Group Management LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Ponoi Management LLC
PONOI CAPITAL LP
Director
10% Owner
193$18$3,47417,976,977
(Indirect
Direct)
View
2020-04-08
Purchase
2020-04-09
5:53 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
112,602$14.95$1,683,40017,721,978
(Direct)
View
2020-04-03
Purchase
2020-04-07
7:23 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
138,315$14.17$1,960,23317,609,376
(Direct)
View
2020-03-31
Purchase
2020-04-02
6:08 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
250,984$12.4$3,111,02117,471,061
(Direct)
View
2020-03-23
Purchase
2020-03-25
7:42 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
301,180$11.89$3,580,54417,220,077
(Direct)
View
2020-03-19
Purchase
2020-03-23
6:59 pm
CONSTELLATION PHARMACEUTICALS INCCNSTCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
41,674$22.48$936,9296,210,531
(Indirect
Direct)
View
2020-03-19
Purchase
2020-03-23
5:06 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
291,546$11.68$3,404,77316,918,897
(Direct)
View
2020-03-05
Purchase
2020-03-06
6:01 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
8,307$18$149,52616,627,351
(Direct)
View
2020-03-02
Purchase
2020-03-04
7:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
62,868$17.97$1,129,42516,619,044
(Direct)
View
2020-02-26
Purchase
2020-02-28
7:12 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
75,447$17.91$1,351,59316,556,176
(Direct)
View
2020-02-06
Purchase
2020-02-10
4:51 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
44,900$15.96$716,60416,480,729
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-05
Other
2024-04-08
8:04 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
1,000$02,000
(Indirect)
View
2024-04-05
Disposition
2024-04-08
8:04 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
20,344,505$02,000
(Indirect)
View

Ownership
2021-08-16
8:16 pm
N/A
N/A
Surrozen Inc.SRZNCOLUMN GROUP III GP LP
COLUMN GROUP III-A LP
COLUMN GROUP III LP
10% Owner
0$09,414,795
(Indirect)
View
2021-08-03
Conversion
2021-08-04
6:34 pm
N/A
N/A
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
10% Owner
18,692,248$04,985,570
(Indirect)
View

Ownership
2021-07-29
8:28 pm
N/A
N/A
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
10% Owner
0$09,400,290
(Indirect)
View
2020-12-14
Exercise
2020-12-16
6:40 pm
N/A
N/A
CONSTELLATION PHARMACEUTICALS INCCNSTCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
COLUMN GROUP GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Kutzkey Tim
10% Owner
30,107$1.556,240,638
(Direct)
View
2020-12-14
Exercise
2020-12-16
6:40 pm
N/A
2021-05-24
CONSTELLATION PHARMACEUTICALS INCCNSTCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
COLUMN GROUP GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Kutzkey Tim
10% Owner
30,107$06,240,638
(Direct)
View
2020-07-21
Exercise
2020-07-23
5:39 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP II LP
COLUMN GROUP GP LP
Column Group II GP LP
Column Group Management LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Ponoi Management LLC
PONOI CAPITAL LP
Director
10% Owner
24,000$13.3517,976,977
(Direct)
View
2019-05-15
Option Award
2020-07-23
5:39 pm
2020-05-15
2029-05-14
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP II LP
COLUMN GROUP GP LP
Column Group II GP LP
Column Group Management LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Ponoi Management LLC
PONOI CAPITAL LP
Director
10% Owner
64,806$017,976,977
(Indirect)
View
2020-07-21
Exercise
2020-07-23
5:39 pm
2020-05-15
2020-08-18
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP II LP
COLUMN GROUP GP LP
Column Group II GP LP
Column Group Management LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Ponoi Management LLC
PONOI CAPITAL LP
Director
10% Owner
24,000$017,976,977
(Direct)
View
2020-06-17
Other
2020-06-19
4:41 pm
N/A
2030-06-16
Revolution Medicines Inc.RVMDCOLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
PONOI CAPITAL LP
Ponoi Capital II LP
Ponoi Management LLC
Ponoi II Management LLC
Kutzkey Tim
GOEDDEL DAVID V
10% Owner
68,720$08,053,338
(Indirect)
View

Ownership
2020-03-23
6:55 pm
N/A
N/A
CONSTELLATION PHARMACEUTICALS INCCNSTCOLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
10% Owner
0$036,135
(Direct)
View
2020-02-18
Conversion
2020-02-18
4:21 pm
N/A
N/A
Revolution Medicines Inc.RVMDCOLUMN GROUP III LP
Svennilson Peter
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
PONOI CAPITAL LP
Ponoi Capital II LP
Ponoi Management LLC
Ponoi II Management LLC
GOEDDEL DAVID V
Kutzkey Tim
10% Owner
15,954,768$07,977,384
(Direct)
View

Ownership
2020-02-12
5:53 pm
N/A
N/A
Revolution Medicines Inc.RVMDCOLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Svennilson Peter
GOEDDEL DAVID V
Kutzkey Tim
10% Owner
0$07,977,384
(Direct)
View
(A) Indicate amendment filing.